Tabula Rasa HealthCare Inc (NASDAQ:TRHC) Director Gordon Tunstall Sells 1,000 Shares

Tabula Rasa HealthCare Inc (NASDAQ:TRHC) Director Gordon Tunstall sold 1,000 shares of the firm’s stock in a transaction dated Wednesday, August 14th. The shares were sold at an average price of $62.64, for a total transaction of $62,640.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.

Gordon Tunstall also recently made the following trade(s):

  • On Wednesday, July 10th, Gordon Tunstall sold 1,000 shares of Tabula Rasa HealthCare stock. The shares were sold at an average price of $52.60, for a total transaction of $52,600.00.
  • On Wednesday, June 19th, Gordon Tunstall sold 1,000 shares of Tabula Rasa HealthCare stock. The shares were sold at an average price of $51.52, for a total transaction of $51,520.00.

TRHC stock traded down $2.18 during mid-day trading on Wednesday, hitting $62.27. 215,018 shares of the company were exchanged, compared to its average volume of 373,886. The business has a 50 day simple moving average of $55.38. The company has a quick ratio of 1.73, a current ratio of 1.80 and a debt-to-equity ratio of 1.31. The firm has a market cap of $1.42 billion, a PE ratio of 183.15 and a beta of 1.63. Tabula Rasa HealthCare Inc has a 1-year low of $40.86 and a 1-year high of $91.16.

Tabula Rasa HealthCare (NASDAQ:TRHC) last issued its quarterly earnings data on Thursday, August 8th. The company reported $0.35 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.06 by $0.29. The firm had revenue of $76.26 million during the quarter, compared to the consensus estimate of $70.40 million. Tabula Rasa HealthCare had a negative net margin of 7.09% and a positive return on equity of 3.91%. The business’s revenue for the quarter was up 56.9% compared to the same quarter last year. During the same period last year, the business posted $0.20 earnings per share. Sell-side analysts predict that Tabula Rasa HealthCare Inc will post -0.55 earnings per share for the current year.

Several brokerages recently issued reports on TRHC. BidaskClub upgraded shares of Tabula Rasa HealthCare from a “buy” rating to a “strong-buy” rating in a research note on Tuesday. TheStreet downgraded shares of Tabula Rasa HealthCare from a “c-” rating to a “d+” rating in a research note on Tuesday, June 11th. Piper Jaffray Companies raised their target price on shares of Tabula Rasa HealthCare from $73.00 to $78.00 and gave the company an “overweight” rating in a research note on Thursday, May 9th. Zacks Investment Research downgraded shares of Tabula Rasa HealthCare from a “buy” rating to a “hold” rating in a research note on Wednesday. Finally, ValuEngine upgraded shares of Tabula Rasa HealthCare from a “hold” rating to a “buy” rating in a research note on Thursday, July 11th. Three analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have issued a strong buy rating to the company. Tabula Rasa HealthCare currently has a consensus rating of “Buy” and a consensus price target of $82.67.

Hedge funds have recently modified their holdings of the business. Legal & General Group Plc increased its stake in Tabula Rasa HealthCare by 0.9% during the fourth quarter. Legal & General Group Plc now owns 36,450 shares of the company’s stock worth $2,305,000 after acquiring an additional 318 shares during the last quarter. State of Alaska Department of Revenue increased its stake in Tabula Rasa HealthCare by 4.1% during the first quarter. State of Alaska Department of Revenue now owns 5,911 shares of the company’s stock worth $333,000 after acquiring an additional 235 shares during the last quarter. Virtu Financial LLC acquired a new stake in Tabula Rasa HealthCare during the first quarter worth about $326,000. Louisiana State Employees Retirement System increased its stake in Tabula Rasa HealthCare by 3.0% during the first quarter. Louisiana State Employees Retirement System now owns 6,600 shares of the company’s stock worth $372,000 after acquiring an additional 193 shares during the last quarter. Finally, Pier Capital LLC increased its stake in Tabula Rasa HealthCare by 151.7% during the first quarter. Pier Capital LLC now owns 147,614 shares of the company’s stock worth $8,328,000 after acquiring an additional 88,968 shares during the last quarter. Hedge funds and other institutional investors own 91.24% of the company’s stock.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the field of medication safety in the United States. The company's proprietary Medication Risk Mitigation Matrix delivers a multi-drug review, which identifies medication-related risks. Its cloud-based software applications include EireneRx, a medication decision-support and e-prescribing platform to access patients' medication-related information; and MedWise that provides medication decision support components for clients seeking to manage their medication risk and improve medication outcomes, and patient relationships by enhancing their existing systems.

See Also: What is the yield curve?

Insider Buying and Selling by Quarter for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.



Comments


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on reddit